Ramon Mohanlal M.D., Ph.D. has left BeyondSpring Inc. (the Company) and stopped serving as the Chief Medical Officer and Executive Vice President of Research and Development of the Company and on the Company's Board of Directors (the Board), effective February 16, 2023. Dr. Mohanlal's departure is not the result of any disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.775 USD | +3.93% | +11.07% | +201.11% |
29/04 | North American Morning Briefing : Investors Brace -2- | DJ |
22/04 | North American Morning Briefing : Stock Futures -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+201.11% | 10Cr | |
+6.62% | 11TCr | |
+11.04% | 11TCr | |
-12.77% | 2.22TCr | |
+0.29% | 2.13TCr | |
-4.50% | 1.9TCr | |
-37.85% | 1.85TCr | |
-10.98% | 1.68TCr | |
+38.66% | 1.25TCr | |
-25.44% | 808.97Cr |
- Stock Market
- Equities
- BYSI Stock
- News BeyondSpring Inc.
- Ramon Mohanlal Left Beyondspring Inc. as the Chief Medical Officer and Executive Vice President